Viele Köpfe - ein Ziel

Ihre Gesundheit!

Klinik & Team

Dr. med. Felix Behling

Funktion: Funktionsoberarzt
Tel: +49 7071 29 0
E-Mail: felix.behling@med.uni-tuebingen.de

Akademische Laufbahn

  • Studium der Humanmedizin an der Georg-August-Universität Göttingen (Approbation 06/2012)
  • Promotion am Institut für Neuropathologie der Georg-August-Universität Göttingen: “Identification of Prognostically Relevant Cellular Markers of Differentiation in Glioblastoma” (Magna cum laude, 09/2016)
  • Beginn der Facharztausbildung in der Klinik für Neurochirurgie der Universitätsklinik Tübingen (07/2013)
  • Facharztbezeichnung Neurochirurgie (08/2019
  • Seit 2021 Lehr- und Prüfungsbeauftragter

Wissenschaftliche Interessen

  • Hirneigene Tumore, Meningeome, Vestibularisschwannome
  • Prognostische, prädiktive und diagnostische Tumormarker
  • Tissue Microrarrays
  • Translationale Neuroonkologie

Publikationen

  • Behling F, Fodi C, Skardelly M, Paulsen F, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J. The prognostic role of the immunohistochemical expression of S100 in meningiomas. J Cancer Res Clin Oncol. 2022 Jul 15. doi: 10.1007/s00432-022-04186-9.
  • Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, Agkatsev S, Blau T, Mäurer I, Kahlert U, Sagerer A, Berberich A, Heider S, Müther M, Bodensohn R, Behling F. Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey. Neuro Oncol. 2022 Sep 1;24(9):1609-1611. doi: 10.1093/neuonc/noac114.
  • Fodi C, Skardelly M, Hempel JM, Hoffmann E, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J, Behling F. Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma. Neurosurg Rev. 2022 Aug;45(4):2993. doi: 10.1007/s10143-022-01817-0.
  • Fodi CK, Schittenhelm J, Honegger J, Castaneda-Vega SG, Behling F. The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas. J Clin Med. 2022 Apr 23;11(9):2364. doi: 10.3390/jcm11092364.
  • Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Georgious T, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ Open. 2022 May 9;12(5):e057384. doi: 10.1136/bmjopen-2021-057384.
  • Behling F, Rang J, Dangel E, Noell S, Renovanz M, Mäurer I, Schittenhelm J, Bender B, Paulsen F, Brendel B, Martus P, Gempt J, Barz M, Meyer B, Tatagiba M, Skardelly M. Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival. Front Oncol. 2022 Feb 16;12:755430. doi: 10.3389/fonc.2022.755430.
  • Islim AI, Millward CP, Piper RJ, Fountain DM, Mehta S, Kolamunnage-Dona R, Ali U, Koszdin SD, Georgious T, Mills SJ, Brodbelt AR, Mathew RK, Santarius T, Jenkinson MD; IMPACT Study Investigators, International Consortium on Meningioma (ICOM) and British Neurosurgical Trainee Research Collaborative (BNTRC). External validation and recalibration of an incidental meningioma prognostic model - IMPACT: protocol for an international multicentre retrospective cohort study. BMJ Open. 2022 Jan 18;12(1):e052705. doi: 10.1136/bmjopen-2021-052705.
  • Engelhardt S, Behling F, Beschorner R, Eckert F, Kohlhof P, Tatagiba M, Tabatabai G, Schuhmann MU, Ebinger M, Schittenhelm J. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors. J Cancer Res Clin Oncol. 2022 Apr;148(4):857-866. doi: 10.1007/s00432-021-03906-x.
  • Behling F. Commentary: Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study. Neurosurgery. 2022 Jan 1;90(1):e7-e8. doi: 10.1227/NEU.0000000000001752.
  • Skardelly M, Kaltenstadler M, Behling F, Mäurer I, Schittenhelm J, Bender B, Paulsen F, Hedderich J, Renovanz M, Gempt J, Barz M, Meyer B, Tabatabai G, Tatagiba MS. A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials. Front Oncol. 2021 Dec 13;11:748691. doi: 10.3389/fonc.2021.748691.
  • Behling F, Fodi C, Wang S, Hempel JM, Hoffmann E, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J, Skardelly M. Increased proliferation is associated with CNS invasion in meningiomas. J Neurooncol. 2021 Dec;155(3):247-254. doi: 10.1007/s11060-021-03892-7. Epub 2021 Nov 20.
  • Barz M, Gerhardt J, Bette S, Aftahy AK, Huber T, Combs SE, Ryang YM, Wiestler B, Skardelly M, Gepfner-Tuma I, Behling F, Schmidt-Graf F, Meyer B, Gempt J. Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study. BMC Neurol. 2021 Nov 15;21(1):446. doi: 10.1186/s12883-021-02424-0.
  • Fodi C, Skardelly M, Hempel JM, Hoffmann E, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J, Behling F. The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma. Neurosurg Rev. 2021 Oct 2. doi: 10.1007/s10143-021-01651-w. Online ahead of print.
  • Nuessle NC, Behling F, Tabatabai G, Castaneda Vega S, Schittenhelm J, Ernemann U, Klose U, Hempel JM. ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging. J Clin Med. 2021 Aug 4;10(16):3451. doi: 10.3390/jcm10163451.
  • Behling F, Bersali I, Santacroce A, Hempel J, Kandilaris K, Schittenhelm J, Tatagiba M. Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery-a case report and review of the literature. Neurosurg Rev. 2021 Aug 15. doi: 10.1007/s10143-021-01620-3. Online ahead of print.
  • Behling F, Hennersdorf F, Schittenhelm J. Epigenome-wide data collection in a case of gliofibroma. Folia Neuropathol. 2021;59(2):212-218. doi: 10.5114/fn.2021.106278.
  • Behling F, Hempel JM, Schittenhelm J. Brain Invasion in Meningioma-A Prognostic Potential Worth Exploring. Cancers (Basel). 2021 Jun 29;13(13):3259. doi: 10.3390/cancers13133259.
  • Hoffmann E, Clasen K, Frey B, Ehlers J, Behling F, Skardelly M, Bender B, Schittenhelm J, Reimold M, Tabatabai G, Zips D, Eckert F, Paulsen F. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy. Radiat Oncol. 2021 Jun 25;16(1):116. doi: 10.1186/s13014-021-01825-2.
  • Hempel JM, Brendle C, Adib SD, Behling F, Tabatabai G, Castaneda Vega S, Schittenhelm J, Ernemann U, Klose U. Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging. J Clin Med. 2021 May 26;10(11):2325. doi: 10.3390/jcm10112325.
  • Nassiri F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng HK, Saladino A, Pollo B, Dimeco F, Yip S, Gao A, Aldape KD, Zadeh G; International Consortium on Meningiomas. Loss of H3K27me3 in meningiomas. Neuro Oncol. 2021 Aug 2;23(8):1282-1291. doi: 10.1093/neuonc/noab036
  • Binswanger J, Kohl C, Behling F, Noell S, Hirsch S, Hickmann AK, Tatagiba MS, Tabatabai G, Hippler M, Renovanz M. Neuro-oncological patients' and caregivers' psychosocial burden during the COVID-19 pandemic-A prospective study with qualitative content analysis. Psychooncology. 2021 Sep;30(9):1502-1513. doi: 10.1002/pon.5713. Epub 2021 May
  • Behling F, Fodi C, Skardelly M, Renovanz M, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J. Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential. Neurosurg Rev. 2021 Apr 26. doi: 10.1007/s10143-021-01552-y. Online ahead of print.
  • Behling F, Nasi-Kordhishti I, Haas P, Sandritter J, Tatagiba M, Herlan S. One-on-one mentoring for final year medical students during the neurosurgery rotation. BMC Med Educ. 2021 Apr 22;21(1):229. doi: 10.1186/s12909-021-02657-0
  • Behling F, Suhm E, Ries V, Gonçalves VM, Tabatabai G, Tatagiba M, Schittenhelm J. COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma. Neurol Res Pract. 2021 Mar 1;3(1):11. doi: 10.1186/s42466-021-00111-6
  • Gonçalves VM, Suhm EM, Ries V, Skardelly M, Tabatabai G, Tatagiba M, Schittenhelm J, Behling F. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers (Basel). 2021 Jan 26;13(3):466. doi: 10.3390/cancers13030466.
  • Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F, Skardelly M, Honegger J, Tatagiba M; International Consortium on Meningiomas, Schittenhelm J, Tabatabai G. H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort. Neuro Oncol. 2021 Aug 2;23(8):1273-1281. doi: 10.1093/neuonc/noaa303.
  • Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Renovanz M, Skardelly M, Bornemann A, Honegger J, Tabatabai G, Tatagiba M, Schittenhelm J. CNS Invasion in Meningioma-How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence. Cancers (Basel). 2020 Dec 3;12(12):3620. doi: 10.3390/cancers12123620
  • Behling F, Fodi C, Hoffmann E, Renovanz M, Skardelly M, Tabatabai G, Schittenhelm J, Honegger J, Tatagiba M. The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy. Neurosurg Rev. 2021 Aug;44(4):2329-2336. doi: 10.1007/s10143-020-01428-7. Epub 2020 Oct 26.
  • Behling F, Barrantes-Freer A, Behnes CL, Stockhammer F, Rohde V, Adel-Horowski A, Rodriguez-Villagra OA, Barboza MA, Brück W, Lehmann, U, Stadelmann C, hartmann C. Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma. 2020 Mar 11;15(3):30229274. doi: 10.1371/journal.pone.0229274. eCollection 2020.
  • Behling F. Commentary: Selective Intensive Care Unit Admission After Adult Supratentorial Tumor Craniotomy: Complications, Length of Stay, and Costs. Neurosurgery. 2019 Oct 31. pii: nyz427. doi: 10.1093/neuros/nyz427. [Epub ahead of print] No abstract available.
  • Christians A, Adel-Horowski A, Banan R, Lehmann U, Bartels S, Behling F, Barrantes-Freer A, Stadelmann C, Rohde V, Stockhammer F, Hartmann C. The prognostic role of IDH mutaitons in homogeneously treated patients with anaplastic astrocytomas and glioblastomas. Acto Neuropathol Commun. 2019 Oct 17;7(1):156. doi: 10.1186/s40478-019-0817-0.
  • Zwirner K, Paulsen F, Schittenhelm J, Gepfner-Tuma I, Tabatabai G, Behling F, Skardelly M, Bender B, Zips D, Eckert F. Integrative assessment of brain and bone invasion in meningioma patients. Radiat Oncol. 2019 Jul 29;14(1):132 doi: 10.1186/s13014-019-1341-x.
  • Behling F, Ries V, Skardelly M, Gepfner-Tuma I, Schuhmann M, Ebner FH, Tabatabai G, Bornemann A, Schittenhelm J, Tatagiba M. COX2 expression is associated with proliferation and tumor expansion in vestibular schwannoma but is not influenced by acetylsalicylic acid intake. Acta Neuropathol Commun.
  • Behling F, Schittenhelm J. Oncogenic BRAF Alterations and Their Role in Brain Tumors. Cancers 2019 Jun 8;11(6). doi: 10.3390/cancers11060794.
  • Schittenhelm J, Krischker N, Gepfner-Tuma I, Behling F, Noell S, Eckert F, Biskup S, Tabatabai G. Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas. Brain Pathol. 2019 Jan 24. doi: 10.1111/bpa.12709.
  • Behling F, Honegger J, Skardelly M, Gepfner-Tuma I, Tabatabai G, Tatagiba M, Schittenhelm J. Hich expression of somatostatin receptors 2A, 3 and 5 in corticotroph pituitary adenoma. Int J Endocrinol. 2018 Dec 9;2018:1763735. doi: 10.1155/2018/1763735.
  • Behling F, Schittenhelm J. Tissue microarrays - translational biomarker research in the fast lane. Expert Rev Mol Diagn. 2018 Oct;18(10):833-835. doi: 10.1080/14737159.2018.1522252.
  • Behling F. Commentary: Inpatient and Postdischarge Outcomes Following Elective Craniotomy for Mass Lesions Neurosurgery. 2018 Sep 4. doi: 10.1093/neuros/nyy398.
  • Zipser CM, Füllbier L, Beschorner R, Bösmüller H, Ziemann U, Tatagiba MS, Tabatabai G, Bender B, Behling F. Intraspinal intradural nodular fasciitis mimicking glioblastoma metastasis: a case report Folia Neuropathol. 2018;56(1):75-79. doi: 10.5114/fn.2018.74662.
  • Skardelly M, Behling F. In Reply to the Letter to the Editor Regarding "The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis" World Neurosurg. 2018 Jan;109:513. doi: 10.1016/j.wneu.2017.10.099.
  • Schäfer S, Behling F, Skardelly M, Koch M, Ott I, Paulsen F, Tabatabai G, Schittenhelm J. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas. Neuropathol Appl Neurobiol. 2017 Oct 20. doi: 10.1111/nan.12447.
  • Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F, Tabatabai G, Tatagiba M, Skardelly M. The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis. World Neurosurg. 2017 Oct;106:615-624. doi: 10.1016/j.wneu.2017.07.034.
  • Breitkopf M, Bisdas S, Liebsch M, Behling F, Bender B, Tatagiba M, Roder C. Safety, Utility, and Clinical Results of Continuous Intraoperative Electrophysiologic Monitoring in 1.5T iMRI-Guided Surgery.World Neurosurg. 2017 Oct;106:198-205. doi: 10.1016/j.wneu.2017.06.054.
  • Skardelly M, Dangel E, Gohde J, Noell S, Behling F, Lepski G, Borchers C, Koch M, Schittenhelm J, Bisdas S, Naumann A, Paulsen F, Zips D, von Hehn U, Ritz R, Tatagiba MS, Tabatabai G. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.May;22(5):570-575. doi: 10.1634/theoncologist.2016-0347.
  • Skardelly M, Rother C, Noell S, Behling F, Wuttke TV, Schittenhelm J, Bisdas S, Meisner C, Rona S, Tabatabai G, Roser F, Tatagiba MS. Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study. World Neurosurg. 2017 Jan;97:538-546. doi: 10.1016/j.wneu.2016.10.062.
  • Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol. 2016 Jun 27;11(1):55. doi: 10.1186/s13000-016-0506-2.
  • Behling F, Hennersdorf F, Bornemann A, Tatagiba M, Skardelly M. 5-Aminolevulinic Acid Accumulation in a Cerebral Infarction Mimicking High-Grade Glioma. World Neurosurg. 2016 Aug;92:586.e5-8. doi: 10.1016/j.wneu.2016.05.009.
  • Behling F, Steinhilber J, Tatagiba M, Bisdas S, Schittenhelm J. IDH1 R132H mutation in a pilocytic astrocytoma: a case report. Int J Clin Exp Pathol. 2015 Sep 1;8(9):11809-13.
  • Skardelly M, Brendle E, Noell S, Behling F, Wuttke TV, Schittenhelm J, Bisdas S, Meisner C, Rona S, Tatagiba MS, Tabatabai G. Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study. Ann Neurol. 2015 Dec;78(6):917-28. doi: 10.1002/ana.24522.
  • Behling F, Ernemann U, Tatagiba MS, Ebner FH. A case of a choroid plexus papilloma mimicking a hemangioblastoma--letter to the editor. Acta Neurochir (Wien). 2015 Oct;157(10):1779-81; discussion 1781. doi: 10.1007/s00701-015-2520-7.

Kongressbeiträge

  • Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Kaltenbach K, Renovanz M, Skardelly M, Nassiri F, Zadeh G, Tatagiba M, Tabatabai G, Schittenhelm J (2020). The prognostic role of H3K27 trimethylation in meningioma. 34. Deutschter Krebskongress, Berlin, Deutschland.
  • Behling F, Ries V, Skardelly M, Ebner F, Schuhmann M, Schittenhelm J, Bornemann A, Tabatabai G, Tatagiba M (2019). COX2 expression is associated with proliferation and tumor expansion of vestibular schwannoma but is not influenced by acetylsalicylic acid intake. 70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Würzburg, Deutschland.
  • Behling F, Ries V, Skardelly M, Ebner F, Schuhmann M, Schittenhelm J, Bornemann A, Tabatabai G, Tatagiba M (2019). COX2 expression is associated with proliferation and tumor expansion of vestibular schwannoma but is not influenced by acetylsalicylic acid intake. Sektionstagung Neuroonkologie der Deutschen Gesellschaft für Neurochirurgie (DGNC), Heidelberg, Deutschland.
  • Behling F, Ries V, Skardelly M, Ebner F, Schuhmann M, Schittenhelm J, Bornemann A, Tabatabai G, Tatagiba M (2019). COX2 expression is associated with proliferation and tumor expansion of vestibular schwannoma but is not influenced by acetylsalicylic acid intake. 21. Jahrestagung der Neuroonkologischen Arbeitsgemeinschaft der Deutschen Krebsgesellschaft (DKG), Mannheim, Deutschland.
  • Behling F, Ries V, Skardelly M, Ebner F, Schuhmann M, Schittenhelm J, Bornemann A, Tabatabai G, Tatagiba M (2019). COX2 expression is associated with proliferation and tumor expansion of vestibular schwannoma but is not influenced by acetylsalicylic acid intake. Trainee lecture of the EANS training course, Moscow, Russia.
  • Behling F, Schittenhelm J, Skardelly M, Tatagiba M, Honegger J (2018). SSTR expression in cortictotroph pituitary adenomas. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Münster, Deutschland.
  • Skardelly M, Kaltenstadler M, Behling F, Noell S, Gepfner-Tuma I, Schittenhelm J, Bender B, Paulsen F, von Hehn U, Renovanz M, Gempt J, Barz M, Meyer B, Tabatabai G, Tatagiba M (2018). The role of resection in glioblastoma -revisited. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Münster, Deutschland.
  • Gerhardt J, Bette S, Gepfner-Tuma I, Skardelly M, Behling F, Ryang Y, Meyer B, Gempt J (2018). Do patients with a poor Karnofsky performance scale profit from tumor volume reduction? 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Münster, Deutschland.
  • Roder C, Behling F, Ernemann U, Hempel J, Bender B, Tatagiba M (2018). Optimization of Diffusion-Weighted Imaging (DWI) in intraoperative MRI (iMRI). 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Münster, Deutschland.
  • Behling F, Roder C (2018). 5-ALA vs. iMRT. 20. Jahrestagung der Neuroonkologischen Arbeitsgemeinschaft (NOA), Köln, Deutschland.
  • Behling F, Decker KH, Hurth H, Birkenhauer U, Steiner J, Tatagiba M, Ebner F (2017). Incidence and intensive care management of intraoperative air embolism in the semisitting position. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Magdeburg, Deutschland.
  • Behling F, Zipser C, Beschorner R, Füllbier L, Skardelly M, Ziehmann U, Tatagiba M (2017). Intradural nodular fasciitis mimicking spinal glioblastoma metastasis. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Magdeburg, Deutschland.
  • Skardelly M, Behling F, Noell, S, Schittenhelm J, Bender B, Tabatabai G, Tatagiba M (2017). The role of resection on overall survival times in recurrent high grade glioma. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Magdeburg, Deutschland.
  • Roder C, Breitkopf M, Bisdas S, Liebsch M, Behling F, Tatagiba M (2017) Safety, value, and feasibility of continuous intraoperative electrophysiological monitoring in 1.5T iMRI-guided surgery. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Magdeburg, Deutschland.
  • Behling F, Noell S, Schittenhelm J, Tabatabai G, Tatagiba M, Skardelly M (2017). The prognostic role of ventricular entry during glioblastoma surgery – a retrospective single center analysis. Jahrestagung der Sektion Neuroonkologie (DGNC), Hamburg, Deutschland.
  • Roder C, Breitkopf M, Bisdas S, Liebsch M, Behling F, Tatagiba M (2017) Safety, value, and feasibility of continuous intraoperative electrophysiological monitoring in 1.5T iMRI-guided surgery. 6th Biannial meeting of the intraoperative imaging society, Hannover, Deutschland.
  • Behling F, Noell S, Schittenhelm J, Tabatabai G, Tatagiba M, Skardelly M (2016). The prognostic role of ventricular entry during glioblastoma surgery – a retrospective single center analysis. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Frankfurt am Main, Deutschland.
  • Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J (2016). Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Frankfurt am Main, Deutschland.
  • Skardelly M, Dangel E, Noell S, Behling F, Tatagiba M, Tabatabai G (2016). Prolonged temozolomide maintenance cycles after concomitant radiotherapy and temozolomide in glioblastoma. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Frankfurt am Main, Deutschland
  • Behling F, Hennersdorf F, Bornemann A, Tatagiba M, Skardelly M (2016). 5-ALA fluorescence in a cerebral infarction mimicking high-grade glioma – a case report. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Frankfurt am Main, Deutschland
  • Behling F, Horowski A, Barrantes-Freer A, Stockhammer F, Hartmann C, Stadelmann C (2015). OLIG2 is an independent prognostic immunohistochemical marker in glioblastoma. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Karlsruhe, Deutschland.
  • Behling F, Ernemann U, Tatagiba M, Ebner FH (2015). CPP mimicking hemangioblastoma. Jahrestagung der Sektion Mikrochirurgie und Neuroanatomie (DGNC), Salzburg, Deutschland.

Mitgliedschaften

  • Deutsche Gesellschaft für Neurochirurgie (DGNC)
  • Gesellschaft für Schädelbasischirurgie (GSB)
  • Deutsche Krebsgesellschaft (DKG)
  • Neuroonkologische Arbeitsgemeinschaft (NOA)
    • Ressortleitung Nachwuchsförderung 2020/2021
    • Vorstand 2021/2022
  • Junge Neuroonkologische Arbeitsgemeinschaft (YoungNOA)
  • European Association of Neurosurgical Societies (EANS)
  • Society for Neurooncology (SNO)

Preise und Förderungen

  • Hans-Joachim Denecke-Preis der Deutschen Gesellschaft für Schädelbasischirurgie (2019)
  • Förderung im Rahmen des Fortüne-Programms: Evaluation von Inflammation, Immunmodulation und Proliferation in Vestibularisschwannomen bezüglich der prognostischen und therapeutischen Wertigkeit (2020)
  • Förderung im Rahmen des PROFIL-Förderlinie für innovative Lehrprojekte: Individualisierte klinisch-praktische Ausbildung im praktischen Jahr – Mentoring in der Neurochirurgie (2019)
  • Preis der Studienkommission Humanmedizin für das Beste digitale Lehrkonzept (iKliC Hirndruck) im Sommersemester 2020

Externe Publikationsdatenbank

Alle Publikationen finden Sie auch sin der externen Publikationsdatenbank. Ein Service der “U.S. National Library of Medicine” und dem “National Institutes of Health”

Externe Publikationsdatenbank